发明名称 PYRAZOLINONE FOR TREATMENT OF DISTURBANCE OF POTENCY
摘要 PURPOSE: A novel compound of formula 1 and physiologically acceptable salts thereof are used for manufacturing medicines by a non-chemical method as an active substance. Therefore, they are useful for the treatment and/or therapy of disturbance of potency. CONSTITUTION: A novel compound is represented by the formmula(1): wherein, R¬1 is unsubstituted or substituted benzyl with alkoxy, unsubstituted or substituted pyridil or phenyl with Hal, CN, COOH, CONH2, CONHA, CONAA¬1, NH2, NH-CO-A, NH-SO2A, SO2NH-CO-A, NA-SO2A¬1, NH-CO-OA, SO3H, SO2NR¬4R¬5, CO-NHSO3H, CO-NHSO2A, tetrazolyl or PO3H for 1-3 times; R¬2 is A, alkoxy-CO-alkylen, HO-CO-alkylen or HO-alkylen; R¬3 is H, A, alkoxy, NH2, NAA¬1, NH-CO-A, or SO2NR¬4R¬5; each R¬4 and R¬5 is independently H or A and they are selectively saturated or unsaturated partially or entirely. R¬4 and R¬5 are alkylen chain of which 1-3 C atoms can be substituted with N and/or 1-2 C atoms can be substituted with 1-2 O atoms or 1-2 S atoms; each A and A¬1 is independently alkyl having 1-6 carbons; and Hal is F, Cl, Br or I
申请公布号 KR20000049086(A) 申请公布日期 2000.07.25
申请号 KR19997003161 申请日期 1999.04.12
申请人 MERCK PATENT GMBH 发明人 ARLT MICHAEL;ROCHUS JONAS;SCHELLING PIERRE;CHRISTADLER MARIA;KLUXEN FRANZ-WERNER
分类号 C07D231/20;A61K31/415;A61K31/4152;A61P15/10;(IPC1-7):A61K31/415 主分类号 C07D231/20
代理机构 代理人
主权项
地址